Swemac Innovation AB has partnered with Priveq Investment to enhance its growth strategy in the orthopedic sector, with the Hansson family retaining majority ownership.

Information on the Target

Swemac Innovation AB ("Swemac") is a prominent developer specializing in innovative solutions for fracture treatment and joint replacement, particularly focusing on hip and upper extremity procedures. Established in 1985 as a spin-off from Saab Combitech, Swemac has undergone significant evolution since the Hansson family acquired its medical implant division in 1997. Building upon a rich history of innovation, the company has consistently developed new products, establishing itself as a key player in the medical technology field.

With a diverse product portfolio protected by multiple patents, Swemac markets its offerings in Scandinavia and Japan, as well as in various international markets. The company's head office is located in Linköping, Sweden, and it currently employs around 80 individuals. Swemac has exhibited strong historical growth and profitability, and with the involvement of Priveq Investment as a minority owner, the company aims to further accelerate its growth trajectory.

Industry Overview in Sweden

The orthopaedic sector in Sweden has seen significant advancements in technology and treatment methods over recent years. Home to many innovative medical technology companies, the country is known for its high standar

View Source

Similar Deals

Rubicon Healthcare Partners PeptiSystems

2024

Growth Equity & Expansion Capital Proprietary & Advanced Pharmaceuticals Sweden
Keensight Capital Bentley Endovascular Group AB

2023

Growth Equity & Expansion Capital Medical Devices & Implants Sweden
Frazier Life Sciences Egetis Therapeutics AB

2023

Growth Equity & Expansion Capital Proprietary & Advanced Pharmaceuticals Sweden
Polaris Distriktstandvården

2023

Growth Equity & Expansion Capital Hospitals, Clinics & Primary Care Services Sweden
Bonnier Capital Safe Life

2023

Growth Equity & Expansion Capital Advanced Medical Equipment & Technology (NEC) Sweden
KKR and Impilo Immedica Pharma

2023

Growth Equity & Expansion Capital Proprietary & Advanced Pharmaceuticals Sweden

Priveq Investment

invested in

Swemac Innovation AB

in 2023

in a Growth Equity & Expansion Capital deal

Disclosed details

Revenue: $24M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert